S. Rampes, MA, V. Patel, MSc, Faculty of Life Sciences & Medicine, King's College London, London.
A. Bosworth, C. Jacklin, National Rheumatoid Arthritis Society, Berkshire.
J Rheumatol. 2021 Dec;48(12):1784-1792. doi: 10.3899/jrheum.201439. Epub 2021 May 15.
To assess the reproducibility of patient-reported tender (TJCs) and swollen joint counts (SJCs) of patients with rheumatoid arthritis (RA) compared to trained clinicians.
We conducted a systematic literature review and metaanalysis of studies comparing patient-reported TJCs and/or SJCs to clinician counts in patients with RA. We calculated pooled summary estimates for correlation. Agreement was compared using a Bland-Altman approach.
Fourteen studies were included in the metaanalysis. There were strong correlations between clinician and patient TJCs (0.78, 95% CI 0.76-0.80), and clinician and patient SJCs (0.59, 95% CI 0.54-0.63). TJCs had good reliability, ranging from 0.51 to 0.85. SJCs had moderate reliability, ranging from 0.28 to 0.77. Agreement for TJCs reduced for higher TJC values, suggesting a positive bias for self-reported TJCs, which was not observed for SJCs.
Our metaanalysis has identified a strong correlation between patient- and clinician-reported TJCs, and a moderate correlation for SJCs. Patient-reported joint counts may be suitable for use in annual review for patients in remission and in monitoring treatment response for patients with RA. However, they are likely not appropriate for decisions on commencement of biologics. Further research is needed to identify patient groups in which patient-reported joint counts are unsuitable.
评估类风湿关节炎(RA)患者报告的压痛关节数(TJC)和肿胀关节数(SJC)与经过培训的临床医生计数的可重复性。
我们对比较 RA 患者的 TJC 和/或 SJC 与临床医生计数的研究进行了系统的文献回顾和荟萃分析。我们计算了相关的汇总估计值。使用 Bland-Altman 方法比较一致性。
荟萃分析纳入了 14 项研究。临床医生和患者的 TJC 之间存在很强的相关性(0.78,95%CI 0.76-0.80),临床医生和患者的 SJC 之间存在中度相关性(0.59,95%CI 0.54-0.63)。TJC 的可靠性良好,范围为 0.51 至 0.85。SJC 的可靠性为中度,范围为 0.28 至 0.77。对于较高的 TJC 值,TJC 的一致性降低,表明自我报告的 TJC 存在正向偏倚,但 SJC 则没有观察到这种情况。
我们的荟萃分析确定了患者报告的 TJC 与临床医生报告的 TJC 之间存在很强的相关性,而 SJC 之间存在中度相关性。患者报告的关节计数可能适用于缓解期患者的年度复查和 RA 患者的治疗反应监测。然而,它们可能不适合用于开始使用生物制剂的决策。需要进一步研究以确定哪些患者群体不适合使用患者报告的关节计数。